Trial NCT00385827

View at ClinicalTrials.gov 
Org. Study IDs: CR012346
Secondary IDs: 2006-001671-38 C0328T07

Last trial update was posted on 2014-08-20

MeSH Interventions

Mitoxantrone Prednisone Siltuximab

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Cancer, Prostate

Stopping Reasons

Prematurely stopped after Independent Data Monitoring Committee (IDMC) evaluation for lack of efficacy.

Limitations And Caveats

Results of few secondary endpoints were not reported as the study was terminated early due to the premature suspension and subsequent halting of study enrollment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID